Other Event

Other Event

Other Adverse Events are non-serious adverse events that exceed a specific frequency threshold (typically 5% within any study arm). These events are reported to provide comprehensive safety information about all noteworthy adverse occurrences during clinical trials. Each other event is categorized by term, organ system, assessment type, and source vocabulary for standardized reporting.

Other Event path is as follows:

Study -> Results Section -> Adverse Events Module -> Other Event

Study -> Results Section -> Adverse Events Module -> Other Event -> Other Event Stats

Other Event


Ignite Creation Date: 2025-12-24 @ 5:37 PM
Ignite Modification Date: 2025-12-25 @ 3:08 PM
NCT ID: NCT03003468
Term: MOVEMENTS INVOLUNTARY
Organ System: Nervous system disorders
Assessment Type: NON_SYSTEMATIC_ASSESSMENT
Source Vocabulary: CTCAEv4
Notes: None
Study: NCT03003468
Study Brief: Pembrolizumab + Imprime PGG for Metastatic Non-small Cell Lung Cancer After Progression on First-Line Therapy: Big Ten Cancer Research Consortium BTCRC-LUN15-017
Other Event Stats (If Any):

Other Event Stats

Group ID # Events # Affected # At Risk View
EG000 0 0 3 View
EG001 1 1 30 View